Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-047287

Pres. & Chief Exec. Officer sold 9,836 shares at $24.29 ($238,916)

  • Pres. & Chief Exec. Officer acquired 6,214 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Option exercise 10b5-1 +6,214 $2.39 $14,851 27,693 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −6,214 $24.29 $150,938 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −1,357 $24.29 $32,962 40,710 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −1,153 $24.29 $28,006 34,602 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −278 $24.29 $6,753 12,368 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −278 $24.29 $6,753 12,368 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −278 $24.29 $6,753 12,368 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Sale 10b5-1 −278 $24.29 $6,753 12,368 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-01 Option exercise · Stock option (right to buy) 10b5-1 −6,214 85,667 D
Open-market sales · 9,836 sh · avg $24.29 · $238,916
Loading xslF345X06/wk-form4_1783369520.xml…